Summary:
Metroplex Clinical Research Center is conducting a Phase 2a Study Evaluating the safety, efficacy, and pharmacodynamic effects of ABT-981 in patients with Knee Osteoarthritis.
Qualified Participants Must:
• Be between 35 and 74 years of age
•
Have been diagnosed with osteoarthritis of knee
•
Have not had a major knee surgery in the past 12 months
Qualified Participants May Receive:
Study medication and procedures at no cost and up to $2025.